← Open Payments lookup

MATTHEW ROSS: Open Payments

NPI 1124601422 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,094 in 93 payments from 16 companies in 2025. Trend: 2023 $1,702 · 2024 $1,882 · 2025 $2,094

Food & beverage: $2,094
CompanyPaymentsAmount
ABBVIE INC.32$588
Salix Pharmaceuticals, a division of Bausch Health US, LLC15$328
Janssen Biotech, Inc.14$301
Gilead Sciences, Inc.6$224
Takeda Pharmaceuticals U.S.A., Inc.6$151
Celltrion USA Inc.5$98
Ardelyx, Inc.4$90
Braintree Laboratories, Inc.2$69
VIVUS LLC2$50
Fresenius Kabi USA, LLC1$35

Products named: XIFAXAN, TREMFYA, RINVOQ, LINZESS, Livdelzi, VEGZELMA, ENTYVIO, IBSRELA.

Industry payments across CA — which companies pay providers there.